Table 1. Expression of bcl-2 in the control and study groups.
| bcl-expression expression | Control group, n (%) | Low grade SIL, n (%) | High grade SIL, n (%) | PVU in situ Carcinoma, n (%) | PVU invasive Carcinoma, n (%) |
|---|---|---|---|---|---|
| Negative (−) | 20/36 (55.5) | 16/32 (50) | 8/22 (36.3) | 8/22 (36.3) | 8/26 (30.8) |
| Negative (1+) | 14/36 (38.9) | 8/32 (25.0) | 2/22 (9.1) | 4/22 (18.2) | 6/26 (23.1) |
| Positive (2+) | 2/36 (5.6) | 2/32 (6.2) | 8/22 (36.3) | 6/22 (27.3) | 8/26 (30.8) |
| Positive (3+) | 0/36 (0) | 6/32 (18.8) | 4/22 (18.2) | 4/22 (18.2) | 4/26 (15.3) |
SIL, squamous intraepithelial lesions; PVU, portio vaginalis uteri.